• About us
• Contact

Advertisement

Organisation › Details

Novalix (Group)

NovAliX is a drug discovery-focused CRO with several unique technologies. It is highly proficient in chemistry and biophysics. The company has set up one of the world’s most comprehensive biophysics platforms, from screening to identification and detailed characterization of drug-target interactions using protein X-ray crystallography, native mass spectrometry, nuclear magnetic resonance (NMR), surface plasmon resonance (SPR) and cryo-electron microscopy. NovAliX’ innovative, cost-effective, collaborative and co-located research programs involve dedicated teams of scientists working throughout Europe in its partners’ laboratories. Close proximity fosters the seamless transfer of knowledge in both directions and speeds up the research process. NovAliX, founded in 2002, is based in Strasbourg, France, in the heart of the BioValley Upper Rhine region, France. *

 

	Start	2008-09-15 merged
	Industry	drug discovery services
	Industry 2	drug development technology
	Person	Jenn, Stephan (Novalix 201011 President)
	Person 2	Zeyer, Denis (Novalix 201011 CEO)
	Region	Illkirch
	Country	France
	Street	Bld. Sébastien Brant BP 30170
	City	67405 Illkirch
	Tel	+33-368-330-200
		Address record changed: 2020-12-02
Basic data	Employees	D: 101 to 500 (2024-08-07)
		* Document for »About Section«: Urania Therapeutics SAS. (11/6/19). "Press Release: Urania Therapeutics Closes a €3.5M Initial Seed Round". Strasbourg.
		Record changed: 2024-08-09

Advertisement

More documents for Novalix (Group)

• [1] Bruker Corporation. (8/7/24). "Press Release: Bruker Announces Strategic Minority Investment in Novalix"....
• [2] Novalix SAS. (11/30/21). "Press Release: Novalix Signs Partnership Agreement to Design and Screen Sanofi’s New DNA-Encoded Libraries". Strasbourg....
• [3] Novalix SAS. (1/25/21). "Press Release: Novalix Partners with Chemical.AI to Develop Artificial Intelligence Toolkit for Drug Discovery". Strasbourg & Wuhan....

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.